Canagliflozin antidiabetic drugs

Invokana

Diabetes type 2

All type of patients:  8 trials  - CANTATA-D - 3005: monotherapy - 3009: Add-on to MET - 3008: Add-on to SU - 3015: Add-on to MET + SU - 3002: Add-on to MET + SU - 3012: Add-on to MET +TZD - 3008: Add-on to insulin

canagliflozin vs placebo

No demonstrated result

canagliflozin vs placebo (add-on MET)

No demonstrated result

canagliflozin vs placebo (add-on MET+SU)

No demonstrated result

canagliflozin vs placebo (add-on MET+TZD)

No demonstrated result

canagliflozin vs placebo (add-on SU)

No demonstrated result